Danian Nie Selected Research

Danian Nie Research Topics

Disease

16	Leukemia 04/2022 - 08/2009
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2021 - 06/2017
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2022 - 12/2012
3	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2022 - 06/2015
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2022 - 01/2021
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 08/2013
2	Neoplasms (Cancer) 01/2021 - 01/2018
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2020 - 10/2018
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Splenic Rupture 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Rheumatoid Arthritis 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Nocardia Infections 01/2021
1	Philadelphia Chromosome 01/2021
1	Residual Neoplasm 12/2020
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020
1	Infections 10/2018
1	Hematologic Neoplasms (Hematological Malignancy) 01/2018
1	Systemic Mastocytosis 09/2017
1	Mast-Cell Leukemia (Leukemia, Mast Cell) 09/2017
1	Mastocytosis 09/2017
1	Invasive Pulmonary Aspergillosis 08/2014
1	Mycoses (Diseases, Fungus) 08/2014
1	Pulmonary Aspergillosis 08/2014

Drug/Important Bio-Agent (IBA)

4	Tyrosine Kinase InhibitorsIBA 09/2021 - 01/2018
3	Imatinib Mesylate (Gleevec)FDA Link 09/2021 - 01/2018
2	Immunosuppressive Agents (Immunosuppressants)IBA 04/2022 - 01/2021
2	Inosine Triphosphate (ITP)IBA 01/2022 - 08/2013
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2018
2	Pharmaceutical PreparationsIBA 08/2014 - 08/2009
2	QuercetinIBA 05/2014 - 01/2011
1	HLA Antigens (Human Leukocyte Antigens)IBA 04/2022
1	Basiliximab FDA Link 01/2022
1	SteroidsIBA 01/2022
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 01/2022
1	Calcineurin InhibitorsIBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	HMGB1 Protein (HMG1)IBA 01/2022
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2022
1	X-Box Binding Protein 1IBA 09/2021
1	Histone-Lysine N-MethyltransferaseIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Dinoprostone (PGE2)FDA Link 01/2020
1	Ferritins (Ferritin)IBA 10/2018
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2018
1	GSK-2816126IBA 01/2018
1	selinexorIBA 01/2018
1	Exportin 1 ProteinIBA 01/2018
1	trkA ReceptorIBA 09/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2017
1	LigandsIBA 09/2017
1	Nerve Growth Factor (NGF)IBA 09/2017
1	CateninsIBA 06/2017
1	Therapeutic UsesIBA 06/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2015
1	Antifungal AgentsIBA 08/2014
1	CytokinesIBA 08/2013
1	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2013
1	Busulfan (Busulfex)FDA Link 02/2013
1	fludarabineIBA 02/2013
1	Bortezomib (Velcade)FDA Link 12/2012
1	Valproic Acid (Depakote)FDA LinkGeneric 12/2012

Therapy/Procedure

7	Hematopoietic Stem Cell Transplantation 01/2021 - 02/2013
6	Therapeutics 01/2022 - 01/2011
5	Transplantation 04/2022 - 02/2013
1	Induction Chemotherapy 07/2022
1	Haploidentical Transplantation 04/2022
1	Splenectomy 01/2022
1	Combination Drug Therapy (Combination Chemotherapy) 01/2021
1	Cell Transplantation 01/2021
1	Drug Therapy (Chemotherapy) 12/2012